Janssen Biotech Inc.

07/28/2023 | Press release | Distributed by Public on 07/28/2023 12:00

Janssen Submits Supplemental New Drug Application to U.S. FDA Seeking Expanded Pediatric Indication for HIV-1 Therapy EDURANT®